Emily Gottschalk serves as Executive at Anixa Biosciences Inc, where they oversee executive responsibilities. Since joining the company, Emily Gottschalk has executed 4 insider transactions totaling $200.5K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jan 5, 2026 involved receiving (via award) 25,000 shares valued at $0.
Emily Gottschalk currently holds 25,000 shares of Anixa Biosciences Inc (ANIX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Emily Gottschalk has been a net buyer of ANIX stock. They have purchased $200.5K and sold $0 worth of shares.
Emily Gottschalk's most recent insider trade was on Jan 5, 2026, when they sold 25,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $3.96 |
| Discretionary |
| Apr 23, 2021 | ANIX | $44.9K | Purchase | 10,000 | $4.49 | Discretionary |
| Mar 25, 2021 | ANIX | $76.1K | Purchase | 15,600 | $4.88 | Discretionary |